Institutional members access full text with Ovid®

Share this article on:

Clinical Application and Assessment of Belotero: A Roundtable Discussion

Lorenc, Z. Paul M.D.; Fagien, Steven M.D.; Flynn, Timothy C. M.D.; Waldorf, Heidi A. M.D.

Plastic and Reconstructive Surgery: October 2013 - Volume 132 - Issue 4S-2 - p 69S–76S
doi: 10.1097/PRS.0b013e31829a0bfc
Cosmetic: Original Articles
Watch Video

Summary: In this final article for the Supplement, the authors address the physical and aesthetic characteristics of the latest hyaluronic acid, Belotero Balance. Topics include unique characteristics of the hyaluronic acid, aesthetic indications, administration techniques, adverse events, and differences between Belotero and other hyaluronic acids. The article closes with a brief discussion about nomenclature of hyaluronic acid products.

New York and Nanuet, N.Y.; Boca Raton, Fla.; and Cary and Chapel Hill, N.C.

From private practice; Cary Skin Center; the Department of Dermatology, University of North Carolina at Chapel Hill; and Mount Sinai School of Medicine.

Received for publication March 7, 2013; accepted April 30, 2013.

Disclosure:Dr. Lorenc is a consultant for Mentor, Merz Aesthetics, Medicis, and Johnson & Johnson. Dr. Fagien is an advisory board member and investigator for Allergan, Medicis, Merz Aesthetics, and Galderma. Dr. Flynn is a consultant for Merz and Canfield Scientific; he has received research support from Merz Aesthetics. Dr. Waldorf is an advisory board member, consultant, and speakers’ bureau member for Merz Aesthetics, Medicis, Allergan, Valeant, Solta, Bropelle, P&G, Johnson & Johnson, Unilever, and Kythera.

Z. Paul Lorenc, M.D., Lorenc Aesthetic Plastic Surgery Center, 983 Park Avenue, New York, N.Y. 10028,

©2013American Society of Plastic Surgeons